These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 17828306)

  • 21. The histone deacetylase inhibitor trichostatin A downregulates human MDR1 (ABCB1) gene expression by a transcription-dependent mechanism in a drug-resistant small cell lung carcinoma cell line model.
    El-Khoury V; Breuzard G; Fourré N; Dufer J
    Br J Cancer; 2007 Aug; 97(4):562-73. PubMed ID: 17667922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of cell cycles and apoptosis by apicidin in estrogen receptor (ER)-positive and-negative human breast cancer cells.
    Im JY; Park H; Kang KW; Choi WS; Kim HS
    Chem Biol Interact; 2008 Apr; 172(3):235-44. PubMed ID: 18313654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The zinc finger repressor, ZBP-89, recruits histone deacetylase 1 to repress vimentin gene expression.
    Wu Y; Zhang X; Salmon M; Zehner ZE
    Genes Cells; 2007 Aug; 12(8):905-18. PubMed ID: 17663720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible mechanism of action of the histone deacetylase inhibitors for the induction of differentiation of HL-60 clone 15 cells into eosinophils.
    Ishihara K; Hong J; Zee O; Ohuchi K
    Br J Pharmacol; 2004 Jul; 142(6):1020-30. PubMed ID: 15210580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2.
    Lin YC; Lin JH; Chou CW; Chang YF; Yeh SH; Chen CC
    Cancer Res; 2008 Apr; 68(7):2375-83. PubMed ID: 18381445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human polyomavirus BKV transcriptionally activates DNA methyltransferase 1 through the pRb/E2F pathway.
    McCabe MT; Low JA; Imperiale MJ; Day ML
    Oncogene; 2006 May; 25(19):2727-35. PubMed ID: 16547506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of p21(WAF1/Cip1) through Sp1 sites by histone deacetylase inhibitor apicidin requires PI 3-kinase-PKC epsilon signaling pathway.
    Kim YK; Han JW; Woo YN; Chun JK; Yoo JY; Cho EJ; Hong S; Lee HY; Lee YW; Lee HW
    Oncogene; 2003 Sep; 22(38):6023-31. PubMed ID: 12955081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A natural histone deacetylase inhibitor, Psammaplin A, induces cell cycle arrest and apoptosis in human endometrial cancer cells.
    Ahn MY; Jung JH; Na YJ; Kim HS
    Gynecol Oncol; 2008 Jan; 108(1):27-33. PubMed ID: 17920664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SULF1 inhibits tumor growth and potentiates the effects of histone deacetylase inhibitors in hepatocellular carcinoma.
    Lai JP; Yu C; Moser CD; Aderca I; Han T; Garvey TD; Murphy LM; Garrity-Park MM; Shridhar V; Adjei AA; Roberts LR
    Gastroenterology; 2006 Jun; 130(7):2130-44. PubMed ID: 16762634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histone deacetylase inhibitor apicidin-mediated drug resistance: involvement of P-glycoprotein.
    Kim YK; Kim NH; Hwang JW; Song YJ; Park YS; Seo DW; Lee HY; Choi WS; Han JW; Kim SN
    Biochem Biophys Res Commun; 2008 Apr; 368(4):959-64. PubMed ID: 18275843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apicidin down-regulates human papillomavirus type 16 E6 and E7 transcripts and proteins in SiHa cervical cancer cells.
    Luczak MW; Jagodzinski PP
    Cancer Lett; 2008 Dec; 272(1):53-60. PubMed ID: 18687520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histone deacetylase inhibitor, apicidin, inhibits human ovarian cancer cell migration via class II histone deacetylase 4 silencing.
    Ahn MY; Kang DO; Na YJ; Yoon S; Choi WS; Kang KW; Chung HY; Jung JH; Min do S; Kim HS
    Cancer Lett; 2012 Dec; 325(2):189-99. PubMed ID: 22781396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nuclear levels and patterns of histone H3 modification and HP1 proteins after inhibition of histone deacetylases.
    Bártová E; Pacherník J; Harnicarová A; Kovarík A; Kovaríková M; Hofmanová J; Skalníková M; Kozubek M; Kozubek S
    J Cell Sci; 2005 Nov; 118(Pt 21):5035-46. PubMed ID: 16254244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. E2F activation of S phase promoters via association with HCF-1 and the MLL family of histone H3K4 methyltransferases.
    Tyagi S; Chabes AL; Wysocka J; Herr W
    Mol Cell; 2007 Jul; 27(1):107-19. PubMed ID: 17612494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histone deacetylase inhibitors inducing human cervical cancer cell apoptosis by decreasing DNA-methyltransferase 3B.
    Liu N; Zhao LJ; Li XP; Wang JL; Chai GL; Wei LH
    Chin Med J (Engl); 2012 Sep; 125(18):3273-8. PubMed ID: 22964322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of DNA methyltransferase 1 by the pRb/E2F1 pathway.
    McCabe MT; Davis JN; Day ML
    Cancer Res; 2005 May; 65(9):3624-32. PubMed ID: 15867357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histone deacetylase inhibitor induction of P-glycoprotein transcription requires both histone deacetylase 1 dissociation and recruitment of CAAT/enhancer binding protein beta and pCAF to the promoter region.
    Kim SN; Kim NH; Lee W; Seo DW; Kim YK
    Mol Cancer Res; 2009 May; 7(5):735-44. PubMed ID: 19435809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of histone deacetylases by chlamydocin induces apoptosis and proteasome-mediated degradation of survivin.
    De Schepper S; Bruwiere H; Verhulst T; Steller U; Andries L; Wouters W; Janicot M; Arts J; Van Heusden J
    J Pharmacol Exp Ther; 2003 Feb; 304(2):881-8. PubMed ID: 12538846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histone deacetylase inhibitors reverse SS18-SSX-mediated polycomb silencing of the tumor suppressor early growth response 1 in synovial sarcoma.
    Lubieniecka JM; de Bruijn DR; Su L; van Dijk AH; Subramanian S; van de Rijn M; Poulin N; van Kessel AG; Nielsen TO
    Cancer Res; 2008 Jun; 68(11):4303-10. PubMed ID: 18519690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histone deacetylase inhibitors--a new tool to treat cancer.
    Somech R; Izraeli S; J Simon A
    Cancer Treat Rev; 2004 Aug; 30(5):461-72. PubMed ID: 15245778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.